During the past decade, Providence Cancer Center at PMCC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 11 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Cancer Center at PMCC" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Providence Cancer Center at PMCC" are "Breast Cancer" (6 trials), "Lung Cancer" (3 trials), "Head and Neck Cancer" (2 trials), "Metastatic Cancer" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Providence Cancer Center at PMCC" in a lesser frequency.

Most popular intervention types in "Providence Cancer Center at PMCC" are "Drug" (10 trials), "Radiation" (7 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "cetuximab" (2 trials), "cisplatin" (2 trials), "paclitaxel" (2 trials) and "3-dimensional conformal accelerated partial breast irradiation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Cancer Center at PMCC" are 7 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Cancer Center at PMCC". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Providence Cancer Center at PMCC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Providence Cancer Center at PMCC, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".